Holen Sie sich die Stockscreener-App
6.4476
2.49%
-0.1824
Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.46%
21.65
|
30.69 | 33.80 | 27.38 | 31.54 |
| Depreciation and Amortization |
17.74%
0.073
|
0.062 | 0.06 | 0.075 | 0.083 |
| Operating Income/Loss |
29.46%
-21.65
|
-30.69 | -33.80 | -27.38 | -31.54 |
| Nonoperating Income/Loss |
70.23%
1.365
|
4.585 | 1.149 | 1.458 | 2.054 |
| Income/Loss From Continuing Operations Before Tax |
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
| Income/Loss From Continuing Operations After Tax |
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
|
Net Income/Loss
|
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
39.95%
60.98
|
43.57 | 33.11 | 0.4327 | 33.06 |
| Diluted Average Shares |
39.95%
60.98
|
43.57 | 33.11 | 0.4327 | 33.06 |
| Basic Earnings Per Share |
45.00%
-0.33
|
-0.60 | -0.99 | -0.78 | -0.89 |
| Diluted Earnings Per Share |
45.00%
-0.33
|
-0.60 | -0.99 | -0.78 | -0.89 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):